Business Context and Reporting Period
Company: EXICURE, INC. (XCUR)
Filing Type: Form 8-K (Current Report)
Date of Report: March 5, 2021 (Event Date)
Reporting Period: Immediate disclosure of corporate governance changes effective March 5, 2021.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding corporate governance and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Director Departure: David R. Walt, Ph.D., notified the Board on March 8, 2021, of his intention not to stand for re-election when his term expires at the 2021 Annual Meeting. The resignation is not the result of any dispute with the Company.
- Director Appointments: The Board appointed Elizabeth Garofalo, M.D., and Andrew Sassine as directors effective March 5, 2021.
- Committee Assignment: Andrew Sassine was appointed as a member of the Audit Committee.
Guidance, Outlook, and Compensation
Management Commentary: The Company issued a press release on March 9, 2021, announcing these governance changes. No financial guidance or operational outlook was provided in this specific filing.
Compensatory Arrangements for New Directors:
- Cash Compensation: $40,000 per fiscal year for Board service; $7,500 per year for Audit Committee service.
- Equity Grant: Each new director received an initial option grant for 100,000 shares of common stock.
- Option Terms: Exercise price of $2.06 per share (closing price on March 5, 2021); vests in equal monthly installments over three years.
Investor Verification Checklist
- Verify the effective date of the new directors' terms (expiring at the 2022 and 2023 Annual Meetings).
- Confirm the vesting schedule and exercise price ($2.06) of the 100,000 share option grants for Dr. Garofalo and Mr. Sassine.
- Review the Company's upcoming 2021 Annual Meeting proxy statement for the final election results regarding Dr. Walt's departure.
- Check subsequent filings for any financial impact related to the new director compensation.